Summary
The propensity of elderly people to suffer from dose-dependent adverse drug reactions is well known. This may be largely related to reduced drug clearance. Changes in liver size and liver blood flow are probably the main reason for this decline in drug elimination with age. This review focuses on methods of measuring liver size and blood flow, on changes which have been reported in the elderly and on the clinical implications of these changes.
Similar content being viewed by others
References
Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. Journal of Pharmacology and Experimental Therapeutics 232: 183–188, 1985
Antal EJ, Kramer PA, Mercik SA, Chapron DJ, Lawson IR. Theophylline pharmacokinetics in advanced age. British Journal of Clinical Pharmacology 12: 637–645, 1981
Bach B, Molholm Hansen J, Kampmann JP, Rasmussen SN, Skorsted L. Disposition of antipyrine and Phenytoin correlated with age and liver volume in man. Clinical Pharmacokinetics 6: 389–396, 1981
Bircher J, Blankart R, Halpern A, Haecki W, Laisue J, et al. Criteria for assessment of functional impairment in patients with cirrhosis of the liver. European Journal of Clinical Investigation 3: 72–85, 1973
Blendis LM, McNeilly WJ, Shepperd L, Williams R, et al. Observer variation in the clinical and radiological assessment of hepatosplenomegaly. British Medical Journal 1: 727–730, 1970
Boyd E. Normal variability in weight of the adult human liver and spleen. Archives of Pathology 16: 350–372, 1983
Bradley SE, Ingelfinger FG, Bradley GP, Curry JJ. The estimation of hepatic blood flow in man. Journal of Clinical Investigation 24: 890–897, 1945
Branch RA, Shand DG, Wilkinson GR, Nies AS. Increased clearance of antipyrine and d-propanolol after phenobarbital treatment in the monkey. Journal of Clinical Investigations 53: 1101–1107, 1974
Calloway NO, Foley CF, Lagerbloom P. Uncertainties in geriatric data II: organ size. Journal of the American Geriatric Society 13: 20–28, 1965
Carr D, Duncan JG, Railton R, Smith CB. Liver volume determination by ultrasound: a feasibility study. British Journal of Radiology 49: 776–778, 1976
Castleden CM, George CF. The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54, 1979
Clarkson MJ, Hardy-Smith A, Richards TG. Measurement of liver blood flow by means of a simple injection of bromosulphthalein without hepatic venous catheterisation. Clinical Science and Molecular Medicine 51: 141–150, 1976
Dunk AA, Jenkins WJ, Burroughs AK, Walt RP, Osuafor TOK, et al. The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease. British Journal of Clinical Pharmacology 16: 117–120, 1983
Editorial. Medication for the elderly. Journal of the Royal College of Physicians of London 18: 7–17, 1984
Eikman EA, Mack GA, Jain VK, Madden JA. Computer-assisted liver mass estimation from gamma-camera images. Journal of Nuclear Medicine 20: 144–148, 1979
Feely J, Crooks J, Stevenson IH. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. British Journal of Clinical Pharmacology 12: 73–78, 1981
Feely J, Wade D, McAllister CB, Wilkinson GR, Robertson D. Effect of hypotension on liver blood flow and lidocaine disposition. New England Journal of Medicine 307: 866–869, 1982
Feely J, Wilkinson GR, Wood AJJ. Reduction of liver blood flow and propranolol metabolism by Cimetidine. New England Journal of Medicine 304: 692–695, 1980
Fritschy P, Robotti G, Schneckloth G, Vock P. Measurement of liver volume by ultrasound and computed tomography. Journal of Clinical Ultrasound 11: 299–303, 1983
George CF. Drug kinetics and hepatic blood flow. Clinical Pharmacokinetics 4: 433–448, 1979
Grainger SL, Kealing PWN, Brown IMH, Marigold JH, Thompson RPH. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clinical Science 64: 207–212, 1983
Grayson J, Johnson DH. The effect of adrenaline and noradrenaline on the liver blood flow. Journal of Physiology 120: 73–94, 1953
Grayson J, Kinnear T. Observations on temperature, blood flow and heat production in the human liver in relation to environment and to glucose and insulin administration. Clinical Science 22: 125–140, 1962
Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI. Antipyrine kinetics in the elderly: prediction of age related changes in benzodiazepine oxidising capacity. Journal of Pharmacology and Experimental Therapeutics 220: 120–126, 1982b
Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. New England Journal of Medicine 306: 1081–1088, 1982a
Homeida M, Roberts CJC, Halliwell M, Read AE, Branch RA. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease. Gut 20: 596–601, 1979
Hurwitz N. Predisposing factors in adverse reactions to drugs. British Medical Journal 1: 536–539, 1969
Iwamoto K, Watanabe J, Araki K, Deguchi N, Sugiyama H. Effect of age on hepatic clearance of propranolol in rats. Journal of Pharmacy and Pharmacology 37: 466–470, 1985
Kan MK, Hopkins GB. Measurement of liver volume by emission computed tomography. Journal of Nuclear Medicine 20: 514–520, 1979
Kato R, Vassanelli P, Frontino G. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochemical Pharmacology 13: 1037–1051, 1964
Kitani K, Setsuko K, Miura R. Hepatic metabolism of sulfobromophthalein in ageing rats. In Kitani (Ed.) Liver and ageing, pp. 145–157, Elsevier Press, Amsterdam, 1978
Kitani K, Zurcher C, Van Bezooijen K. The effect of ageing on the hepatic metabolism of sulfobromophthalein in BN/Bi female and WAG/Rij male and female rats. Mechanisms of Ageing and Development 7: 381–393, 1981
Kolin A. An electromagnetic flowmeter: principle of the method and its application to blood flow measurements. Proceedings of the Society of Experimental and Biological Medicine 35: 43–56, 1936
Lebrec D, Goldfarb G, Benhamou JP. Reduction of liver blood flow by Cimetidine. New England Journal of Medicine 305: 100, 1981
Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. Journal of Clinical Investigation 41: 1169–1180, 1962
Leung NWY, Farrant P, Peters TJ. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. Journal of Hepatology 2: 157–164, 1986
Lorber SH, Oppenheimer MJ, Shay H, Lynch P, Siplet H. Enterohepatic circulation of bromosulphthalein in intraduodenal, intraportal and intravenous dye administration in dogs. American Journal of Physiology 173: 259–264, 1953
Macnab MSP, Macrae DJ, Guy E, Grant IS, Feely J. Profound reduction in morphine clearance and liver blood flow in shock. Intensive Care Medicine 12: 366–369, 1986
Maloney AG, Schmucker DL, Vessey DS, Wang RK. The effects of ageing on the hepatic microsomal mixed-function oxidase system of male and female monkeys. Journal of Hepatology 6: 282–287, 1986
Meyhoff HH, Roder O, Andersen B. Palpatory estimation of liver size — within and between observer variation. Acta Chirurgica Scandinavica 145: 479–481, 1979
Moriyasu F. A new method of transcutaneous measurement of portal blood flow by an ultrasonic ‘Duplex’ system composed of a pulsed doppler flowmeter and a linear-type real-time B-mode electroscanner. Acta Hepatology (Japan) 24: 537, 1983
Nation RL, Learoyd B, Barber J, Triggs EJ. The pharmacokinetics of chlormethiazole following intravenous administration in the aged. European Journal of Clinical Pharmacology 10: 407–415, 1976
Nation RL, Triggs EG, Selig M. Lignocaine kinetics in cardiac patients and aged subjects. British Journal of Clinical Pharmacology 4: 439–448, 1977
Ohnhaus EE. Methods of assessment of the effect of drugs on liver blood flow in man. British Journal of Clinical Pharmacology 7: 223–229, 1979
Ohnhaus EE, Locher JTh. Liver blood flow and blood volume following chronic phenobarbitone administration. European Journal of Pharmacology 31: 161–165, 1975
Pirttiaho HI, Sotaniemi EA, Ahokas JT, Pirkanen U. Liver size indices of drug metabolism in epileptics. British Journal of Clinical Pharmacology 6: 273–278, 1978
Raeth U, Johnson PJ, Williams R. Ultrasound determination of liver size and assessment of patients with malignant liver disease. Liver 4: 287–293, 1984
Rasmussen SN. Liver volume determination by ultrasonic scanning. British Journal of Radiology 45: 579–585, 1972
Roberts RK, Branch RA, Desmond PV, Schenker S. The influence of liver disease on drug disposition. Clinics in Gastroenterology 8(1): 105–121, 1979
Rollo FD, DeLand FH. The determination of liver mass from radionuclide images. Radiology 91: 1191–1194, 1968
Salen SAM, Rajjayabu P, Sheperd AMM, Stevenson IH. Reduced induction of drug metabolism in the elderly. Age and Ageing 7: 68–73, 1978
Sato T, Miwa T, Tauchi H. Age changes in the human liver of different races. Gerontologia 16: 368–380, 1970
Schenk WG, McDonald JC, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in experimental animals. Annals of Surgery 156: 463–471, 1962
Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. Journal of Hepatology 3: 164–171, 1986
Sellers EM, Frecker RC, Romach MK. Drug metabolism in the elderly: confounding of age, smoking and ethanol effects. Drug Metabolism Reviews 14(2): 225–250, 1983
Sherlock S, Beam AG, Billing BH, Paterson JCS. Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow. Journal of Laboratory and Clinical Medicine 35: 923–932, 1950
Spoelstra P, Teunissen MWE, Janssens AR, Weeda B, Van Duijn W. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking. European Journal of Clinical Investigation 16: 321–327, 1986
Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, et al. Technetium-99m NGA functional hepatic imaging preliminary clinical experience. Journal of Nuclear Medicine 26(11): 1233–1242, 1985
Sutter MA, Wood G, Williamson LS, Strong R, Pickham K, et al. Comparison of the hepatic mixed function oxidase system of young, adult and old non-human primates (Macaca nemestrina). Biochemical Pharmacology 34: 2983–2987, 1985
Swift CG, Homeida M, Halliwell M, Roberts CJC. Antipyrine disposition and liver size in the elderly. European Journal of Clinical Pharmacology 14: 149–152, 1978
Thompson EN, Williams R. Effect of age on liver function with particular reference to bromsulphelein excretion. Gut 6: 266–269, 1965
Van Thiel DH, Hagler NG, Shade RR, Skolnick ML, Pollitt Heyl A, et al. In vivo hepatic volume determination using sonography and computed tomography. Gastroenterology 88: 1812–1817, 1985
Vestal RE, Norris AH, Tobin JD, Cohen DH, Shock MW, et al. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432, 1975
Vestal RE, Wood AJJ, Branch RA, Shand DG, Wilkinson GR. Effects of age and cigarette smoking on propranolol disposition. Clinical Pharmacology and Therapeutics 26(1): 8–15, 1979
Vetter H, Falkner R, Neumayr A. The disappearance of colloidal radiogold from the circulation and its application to the estimation of liver blood flow in normal and cirrhotic subjects. Journal of Clinical Investigations 33: 1594–1602, 1954
Walk L. Liver size and its post-mortem changes. Radiologe 23: 189–191, 1983
Weigand BD, Ketterer SG, Rapaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. American Journal of Digestive Diseases 5: 427–436, 1960
Wells PG, Feely J, Wilkinson GR, Wood AJJ. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing. Clinical Pharmacology and Therapeutics 33(5): 603–608, 1983
Williams FM, Wynne HA, Woodhouse KW, Rawlins MD. Plasma aspirin esterase and cholinesterases in the elderly. British Journal of Clinical Pharmacology 24: 272P, 1987
Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG. Effect of ageing and cigarette smoking on antipyrine and indocyanine green elimination. Clinical Pharmacology and Therapeutics 26: 16–20, 1979
Woodhouse KW, Mortimer O, Wiholm BE. Hepatic adverse drug reactions: the effect of age. In Liver and ageing: liver and brain, pp. 75–80, Elsevier, Amsterdam, 1986
Woodhouse KW, Mutch E, Williams FM, James OFW. The effect of age on pathways of drug metabolism in human liver. Age and ageing 13: 328–334, 1984
Woodhouse KW, Williams F, Mutch E, Wynne H, Rawlins M, et al. Phase I drug metabolism in ageing. In Falk Symposium No. 47, Ageing and Gastrointestinal Tract, pp. 255–265, MTP Press, Lancaster, 1988
Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology, in press, 1988b
Wynne H, Mutch E, James OFW, Rawlins M, Woodhouse KW. Effect of age on monooxygenase enzyme kinetics in rat liver microsomes. Age and Ageing 16: 153–158, 1987
Wynne H, Mutch E, James OFW, Wright IP, Rawlins M, et al. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver. Age and Ageing, in press, 1988a
Zoli M, Marchesini G, Melli A, et al. Evaluation of liver volume and liver function following hepatic resection in man. Liver 6: 286–291, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woodhouse, K.W., Wynne, H.A. Age-Related Changes in Liver Size and Hepatic Blood Flow. Clin-Pharmacokinet 15, 287–294 (1988). https://doi.org/10.2165/00003088-198815050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198815050-00002